国泰君安创新医药混合发起A(014157)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
- |
- |
- |
- |
| 存出保证金 |
- |
- |
- |
- |
| 交易性金融资产 |
123,154,099.17 |
158,290,871.48 |
87,677,548.14 |
99,257,053.06 |
| 其中：股票投资 |
123,154,099.17 |
158,290,871.48 |
87,677,548.14 |
99,257,053.06 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
32,988.60 |
- |
- |
- |
| 应收申购款 |
10,801.29 |
357,882.87 |
4,836.77 |
23,304.61 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
151,604,967.31 |
236,773,089.20 |
106,520,070.53 |
119,232,449.29 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
- |
- |
- |
| 应付赎回款 |
603,494.67 |
4,306,168.23 |
7,555.61 |
23,439.31 |
| 应付管理人报酬 |
153,829.62 |
220,664.98 |
108,878.97 |
122,896.96 |
| 应付托管费 |
25,638.26 |
36,777.50 |
18,146.49 |
20,482.85 |
| 应付销售服务费 |
15,182.16 |
30,369.20 |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
74,396.65 |
150,145.42 |
74,590.88 |
150,073.29 |
| 负债合计 |
872,541.36 |
4,744,125.33 |
209,171.95 |
316,892.41 |
| 所有者权益 |
| 实收基金 |
174,341,914.04 |
288,717,101.62 |
135,691,976.08 |
139,837,615.31 |
| 未分配利润 |
-23,609,488.09 |
-56,688,137.75 |
-29,381,077.50 |
-20,922,058.43 |
| 所有者权益合计 |
150,732,425.95 |
232,028,963.87 |
106,310,898.58 |
118,915,556.88 |
| 负债及所有者权益总计 |
151,604,967.31 |
236,773,089.20 |
106,520,070.53 |
119,232,449.29 |
微信公众号
证券之星APP
基本资料
